Literature DB >> 23414263

Resistance in Escherichia coli: variable contribution of efflux pumps with respect to different fluoroquinolones.

A Huguet1, J Pensec, C Soumet.   

Abstract

AIMS: Resistance to fluoroquinolones is partially the result of a decrease in drug accumulation in Escherichia coli through different mechanisms. However, the variable contribution of these mechanisms with respect to different fluoroquinolones is poorly investigated. Therefore, the current study aimed to compare the contribution of resistance attributed to efflux-mediated mechanisms for different fluoroquinolones. METHODS AND
RESULTS: Susceptibility of enrofloxacin, marbofloxacin and ciprofloxacin were compared after treatment with an efflux pump inhibitor in 17 ciprofloxacin-resistant E. coli isolates, and also the expression profile of the genes encoding the porins and efflux pumps involved in this resistance was evaluated. After treatment with the efflux pump inhibitor Phe-Arg-β-naphthylamide (PAβN), susceptibilities differed significantly between antimicrobial agents, the decrease for MIC being higher for enrofloxacin than for marbofloxacin or ciprofloxacin. AcrB expression level increased significantly (+26%) in ciprofloxacin-resistant E. coli isolates compared with ciprofloxacin-susceptible isolates, whereas the expression level decreased for ompF (-50%) and ompC (-30%).
CONCLUSIONS: There was a higher contribution of resistance nodulation division (RND) efflux pumps to resistance to hydrophobic fluoroquinolones. SIGNIFICANCE AND IMPACT OF THE STUDY: Comparison between expression profile of efflux pumps and hydrophobicity of the antimicrobial agents could result in variable resistance for different fluoroquinolones.
© 2013 The Society for Applied Microbiology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23414263     DOI: 10.1111/jam.12156

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  12 in total

1.  Effect of six fluoroquinolones on the expression of four efflux pumps in the multidrug resistant Escherichia coli isolates.

Authors:  Haixia Liu; Xiaoqiang Liu; Yinqian Li; Caiju Hao
Journal:  World J Microbiol Biotechnol       Date:  2015-04-09       Impact factor: 3.312

2.  The Global Regulatory Cyclic AMP Receptor Protein (CRP) Controls Multifactorial Fluoroquinolone Susceptibility in Salmonella enterica Serovar Typhimurium.

Authors:  Stefani C Kary; Joshua R K Yoneda; Stephen C Olshefsky; Laura A Stewart; Steven B West; Andrew D S Cameron
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

3.  Mutations That Enhance the Ciprofloxacin Resistance of Escherichia coli with qnrA1.

Authors:  Laura Vinué; Marian A Corcoran; David C Hooper; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

4.  Antibiotics Combinations and Chitosan Nanoparticles for Combating Multidrug Resistance Acinetobacter baumannii.

Authors:  Nancy G Banoub; Sarra E Saleh; Hala S Helal; Khaled M Aboshanab
Journal:  Infect Drug Resist       Date:  2021-08-20       Impact factor: 4.003

5.  An investigation of the impact of triclosan adaptation on Proteus mirabilis clinical isolates from an Egyptian university hospital.

Authors:  Engy Elekhnawy; Fatma Sonbol; Ahmed Abdelaziz; Tarek Elbanna
Journal:  Braz J Microbiol       Date:  2021-04-07       Impact factor: 2.476

6.  Pharmacokinetic and Pharmacodynamic Evaluation of Marbofloxacin and PK/PD Modeling against Escherichia coli in Pigs.

Authors:  Zhixin Lei; Qianying Liu; Jincheng Xiong; Bing Yang; Shuaike Yang; Qianqian Zhu; Kun Li; Shishuo Zhang; Jiyue Cao; Qigai He
Journal:  Front Pharmacol       Date:  2017-08-21       Impact factor: 5.810

7.  Multiple mechanisms contributing to ciprofloxacin resistance among Gram negative bacteria causing infections to cancer patients.

Authors:  Samira M Hamed; Walid F Elkhatib; Hadir A El-Mahallawy; Mai M Helmy; Mohamed S Ashour; Khaled M A Aboshanab
Journal:  Sci Rep       Date:  2018-08-16       Impact factor: 4.379

8.  Absence, loss-of-function, or inhibition of Escherichia coli AcrB does not increase expression of other efflux pump genes supporting the discovery of AcrB inhibitors as antibiotic adjuvants.

Authors:  Maria Laura Ciusa; Robert L Marshall; Vito Ricci; Jack W Stone; Laura J V Piddock
Journal:  J Antimicrob Chemother       Date:  2022-02-23       Impact factor: 5.790

9.  Inhibitory Concentrations of Ciprofloxacin Induce an Adaptive Response Promoting the Intracellular Survival of Salmonella enterica Serovar Typhimurium.

Authors:  Sushmita Sridhar; Sally Forrest; Derek Pickard; Claire Cormie; Emily A Lees; Nicholas R Thomson; Gordon Dougan; Stephen Baker
Journal:  mBio       Date:  2021-06-22       Impact factor: 7.867

10.  A whole-genome screen identifies Salmonella enterica serovar Typhi genes involved in fluoroquinolone susceptibility.

Authors:  A Keith Turner; Sabine E Eckert; Daniel J Turner; Muhammud Yasir; Mark A Webber; Ian G Charles; Julian Parkhill; John Wain
Journal:  J Antimicrob Chemother       Date:  2020-09-01       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.